AKCEA THERAPEUTICS, INC. 3 SEC Filings

Filed On	Filing
10 Jul 2020	Form 3: Andrews William T., Chief Medical Officer No securities owned
19 May 2020	Form 3: Price Michael Dennis, Chief Financial Officer No securities owned
16 Mar 2020	Form 3: Patterson Joshua F., General Counsel Holds 11,169 shares of Common Stock
13 Feb 2020	Form 3: Salzman Amber, Director No securities owned
16 Dec 2019	Form 3: Yanni Barbara, Director No securities owned
04 Dec 2019	Form 3: Howarth Alex G., Chief Operating Officer No securities owned
23 Oct 2019	Form 3: Jenne Kyle, Chief Commercial Officer Holds 11,711 shares of Common Stock
23 Sep 2019	Form 3: Yang Michael J., Director No securities owned
23 Sep 2019	Form 3: Klein Joseph Iii, Director No securities owned
11 Oct 2018	Form 3: McDevitt Damien, Director No securities owned
05 Jun 2018	Form 3: Moscicki Richard A, Director No securities owned
18 Apr 2018	Form 3: Boyce Sarah, Director No securities owned
05 Sep 2017	Form 3: MacLean Michael F, Chief Financial Officer No securities owned
13 Jul 2017	Form 3: Ionis Pharmaceuticals Inc, 10% owner
13 Jul 2017	Form 3: Crooke Stanley T, Director Holds 0 shares of No securities are beneficially owned.
13 Jul 2017	Form 3: Parshall B Lynne, Director Holds 0 shares of No securities are beneficially owned.
13 Jul 2017	Form 3: Fitzgerald Edward M, Director
13 Jul 2017	Form 3: Gabrieli Christopher, Director
13 Jul 2017	Form 3: Hochberg Elaine, Director
13 Jul 2017	Form 3: Smith Sandford D, Director

Comments